Tri-Activ Disinfectant Spray For Multi-Surfaces is 99.9% Effective Against the Covid-19 Virus in 1 Minute
Piramal Pharma Consumer Products Division’s Tri-Activ Disinfectant Spray For Multi-Surfaces is 99.9% Effective Against the Covid-19 Virus in 1 Minute
Piramal
Pharma Limited’s Consumer Products Division today announced that its Tri-Activ Disinfectant
Spray for multi-surfaces is “99.9% effective against the Covid-19 virus in 1
minute”. This spray has been tested and proven for efficacy as well as fast
action on the Covid-19 virus by an independent accredited US-based lab.
The
Tri-Activ Disinfectant Spray can be used to disinfect a variety of hard and
soft surfaces including delivery parcels, non-leather car interiors and shoes, glass
table tops, door handles and knobs, lift buttons, children’s toys and cycles, and
non-satin clothes, sofas, curtains and mattresses. Its regular usage also keeps
fungus and mould away from high touch surfaces. This spray is available in 3
pack sizes – 100ml (convenient to carry), 230ml (medium) and 500ml (large) at
affordable prices.
Nandini Piramal, Director, Piramal
Pharma Limited said, “With the threat of Covid-19 and the
uncertainty around it, the demand for sanitization and disinfectant products is
on a significant rise as personal hygiene and environment sanitization is of
paramount importance. Piramal’s Consumer Products Division launched the Tri-Active
range of products with an aim to provide complete protection to its consumers
by catering to their various personal and household needs. Our Tri-Activ
Disinfectant Spray is tested and proven to be 99.9% effective against the
corona virus in 1 minute. Committed to our purpose of Doing Well and Doing
Good, we’re now enabling more consumers to make their world ‘Tri-Activ’ safe.”
Piramal’s
Consumer Products Division recently launched its disinfectant product portfolio
under the brand name Tri-Activ in Q1 FY2021. The products under this portfolio
offer customers a complete range of protection from virus, bacteria and other
germs. In addition to having adopted a WHO approved hand sanitizer liquid, this
range comprises a variety of products including disinfectant spray, hand
sanitizer gel, multi-purpose disinfectant liquid, as well as a 6-layer
protective face mask with an anti-virus coating.
Adopting
an e-commerce first strategy, the complete Tri-Activ range of products is
available across all major sales channels including general trade, modern trade
and leading e-commerce platforms. Tri-Activ sprays and sanitizers are available
at 50,000+ outlets in 177 towns in India across chemist and non-chemist
channels. Currently, ~3,000 Tri-Activ range products are sold daily over
e-commerce, contributing to ~50% of the range’s total sales.
About Piramal India
Consumer Products Division:
Piramal Pharma’s India Consumer Products
Division’s portfolio comprises 20 brands with
offerings spanning across multiple categories. It aims to be among the top
three over the-counter (OTC) product companies in India. Over the last two
years, the business has invested significantly in various growth levers. The
Company’s strategy of expanding the product portfolio and distribution network
has worked well and the Consumer Products business is evolving into a strong
player in India’s OTC market.
For more information visit: Piramal Pharma Limited – Consumer Products
Division
About Piramal Enterprises
Ltd:
Piramal
Enterprises Limited (PEL), a publicly listed company
in India, has diversified business interests in Financial Services and
Pharmaceuticals. PEL’s consolidated revenues were ~US$1.7 billion in FY2020,
with ~34% of revenues generated from outside India.
Piramal
Pharma Limited (PPL), a subsidiary of PEL, offers a portfolio of differentiated
products and services through end-to-end manufacturing capabilities across 14
global facilities and a global distribution network in over 100 countries. PPL
includes: Pharma Solutions, an integrated contract development and
manufacturing (CDMO) business; Critical Care, a complex hospital generics
business and the Consumer Healthcare business, selling over-the-counter
products in India. In addition, it has a joint venture with Allergan, a leader
in ophthalmology in the Indian formulations market. In October 2020, PPL
received 20% strategic growth investment from the Carlyle Group.
In
Financial Services, the Company offers a wide range of financial products and
solutions, with exposure across both wholesale and retail financing. The
wholesale lending business provides financing to real estate developers, as
well as corporate clients in non-real estate sectors. Within retail lending,
the Company offers housing loans to individual customers and is building a
multi-product retail lending platform. India Resurgence Fund (IndiaRF), the
distressed asset investing platform in partnership with Bain Capital Credit,
invests in equity and/or debt across non-real estate sectors. The Company has
long-standing partnerships with leading institutional investors that include -
CPPIB, APG, Bain Capital Credit, CDPQ, and Ivanhoé Cambridge. PEL also has
equity investments in the Shriram Group, a leading financial conglomerate in
India.
For more
information visit: www.piramal.com, Facebook, Twitter, LinkedIn
إرسال تعليق